While the pathophysiology of spinal sarcopenia is complex, several studies have discussed the mechanism which leads to skeletal muscle atrophy, including insulin resistance, myostatin activation, mitochondrial function, and glucocorticoid response [21,22,23,24,25]. The gene discussed is INS; the disease is sarcopenia.